Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2013

Qualitative Drug Screen Testing

Effective for claims processed beginning November 1, 2013, and consistent with Centers for Medicare and Medicaid Services (CMS) guidelines, Harvard Pilgrim will no longer reimburse qualitative drug screen testing for the following CPT codes:

  • 80100—Drug screen, qualitative; multiple drug classes chromatographic method, each procedure
  • 80101—Drug screen, qualitative; single drug class method (e.g., immunoassay, enzyme assay), each drug class
  • 80104—Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure

Instead, when reporting qualitative drug screens, please use either of the following HCPCS codes:

  • G0431—Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
  • G0434—Drug screen, other than chromatographic; any number of drug classes, by CLIA waived test or moderate complexity test, per patient encounter

Harvard Pilgrim only reimburses for screenings that are medically necessary for the purposes of diagnosis and/or treatment and are ordered by an authorized prescriber who is providing treatment to the member.

For additional information, please see the updated Non-Covered Services and the Laboratory & Pathology payment policies.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version


Cardiac Medication Adherence Report Now Available

Reminder: Maintain Up-To-Date Panel Status Information


Intralesional Injection Procedures: No Prior Authorization Required

Medical Criteria for Electric and Myoelectric Prosthetics

TMS Now Covered with Prior Authorization

Continuous Glucose Monitoring Systems

New Prior Authorization Requirement for Six Medications

Gastric Emptying Payment Policy Update

P&T Committee Updates

Specialty Pharmacy Updates

Recognizing Postpartum Depression in the Primary Care Setting


Changes to HPHConnect New User Accounts

Qualitative Drug Screen Testing


Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,

Kristin Edmonston,
Production Coordinator